Pediatric exclusivity gives drugmakers six extra months of market protection after patent expiry by blocking generic approvals-not by extending patents, but by delaying FDA approval of competing drugs. It's a powerful, legally backed tool that affects all forms of a drug with the same active ingredient.
Read More